132 related articles for article (PubMed ID: 17991200)
1. Role of leptin in reverse epidemiology in chronic kidney disease.
Scholze A; Tepel M
Semin Dial; 2007; 20(6):534-8. PubMed ID: 17991200
[TBL] [Abstract][Full Text] [Related]
2. Low serum leptin predicts mortality in patients with chronic kidney disease stage 5.
Scholze A; Rattensperger D; Zidek W; Tepel M
Obesity (Silver Spring); 2007 Jun; 15(6):1617-22. PubMed ID: 17558000
[TBL] [Abstract][Full Text] [Related]
3. Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system.
Mallamaci F; Tripepi G; Zoccali C
J Nephrol; 2005; 18(4):464-8. PubMed ID: 16245256
[TBL] [Abstract][Full Text] [Related]
4. Untangling the heavy cardiovascular burden of obesity.
Lavie CJ; Milani RV; Ventura HO
Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):428-9. PubMed ID: 18521107
[TBL] [Abstract][Full Text] [Related]
5. Nutritional and inflammatory status of hemodialysis patients in relation to their body mass index.
Beberashvili I; Sinuani I; Azar A; Yasur H; Feldman L; Efrati S; Averbukh Z; Weissgarten J
J Ren Nutr; 2009 May; 19(3):238-47. PubMed ID: 19243974
[TBL] [Abstract][Full Text] [Related]
6. Circulating adipocytokines in obese nondiabetic patients in relationship with cardiovascular risk factors, anthropometry and resting-energy expenditure.
de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O; Romero E
Ann Nutr Metab; 2007; 51(5):416-20. PubMed ID: 18025813
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between serum leptin and tumor necrosis factor and endothelin in patients with chronic renal failure].
Zhang DY; Yang LC; Zhang J; Zhang XL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):750-2. PubMed ID: 15585153
[TBL] [Abstract][Full Text] [Related]
8. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.
Stringer DM; Sellers EA; Burr LL; Taylor CG
Pediatr Diabetes; 2009 Jun; 10(4):269-77. PubMed ID: 19175895
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease.
Zoccali C; Mallamaci F; Tripepi G
Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V67-72. PubMed ID: 15284363
[TBL] [Abstract][Full Text] [Related]
10. Adipocytokines leptin and adiponectin, and measures of malnutrition-inflammation in chronic renal failure: is there a relationship?
Dervisoglu E; Eraldemir C; Kalender B; Kir HM; Caglayan C
J Ren Nutr; 2008 Jul; 18(4):332-7. PubMed ID: 18558297
[TBL] [Abstract][Full Text] [Related]
11. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
[TBL] [Abstract][Full Text] [Related]
12. Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.
Popa C; Netea MG; de Graaf J; van den Hoogen FH; Radstake TR; Toenhake-Dijkstra H; van Riel PL; van der Meer JW; Stalenhoef AF; Barrera P
J Rheumatol; 2009 Apr; 36(4):724-30. PubMed ID: 19273452
[TBL] [Abstract][Full Text] [Related]
13. Short-term beta-adrenergic regulation of leptin, adiponectin and interleukin-6 secretion in vivo in lean and obese subjects.
Goossens GH; Jocken JW; van Baak MA; Jansen EH; Saris WH; Blaak EE
Diabetes Obes Metab; 2008 Nov; 10(11):1029-38. PubMed ID: 18435774
[TBL] [Abstract][Full Text] [Related]
14. Cardiac autonomic nervous system activity in obesity.
Liatis S; Tentolouris N; Katsilambros N
Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():476-83. PubMed ID: 16444178
[TBL] [Abstract][Full Text] [Related]
15. Leptin in acute coronary syndromes: has the time come for its use in risk stratification?
Amasyali B; Kose S; Kursaklioglu H; Kilic A; Isik E
Int J Cardiol; 2008 Nov; 130(2):264-5. PubMed ID: 17669522
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of adiponectin, leptin, and tumour necrosis factor alpha in hypertension.
Patel JV; Lim HS; Dubb K; Hughes EA; Lip GY
Ann Med; 2009; 41(4):291-300. PubMed ID: 19172446
[TBL] [Abstract][Full Text] [Related]
17. Serum leptin, insulin resistance, and body fat after renal transplantation.
Souza GC; Costa C; Scalco R; Gonçalves LF; Manfro RC
J Ren Nutr; 2008 Nov; 18(6):479-88. PubMed ID: 18940650
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.
Poulain M; Doucet M; Drapeau V; Fournier G; Tremblay A; Poirier P; Maltais F
Chron Respir Dis; 2008; 5(1):35-41. PubMed ID: 18303100
[TBL] [Abstract][Full Text] [Related]
19. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
Rubin C; Nolin TD; Himmelfarb J
Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):506-11. PubMed ID: 18089962
[TBL] [Abstract][Full Text] [Related]
20. [Obesity--the risk factor of cardiovascular disease in patients with chronic kidney disease?].
Lizicárová D; Hirnerová E; Krahulec B
Vnitr Lek; 2010 Oct; 56(10):1088-92. PubMed ID: 21105458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
